CLINICAL_TRIALS
trial_result
· 2021-03-23
Clinical Trial Update: Clinical Study on Wuling Powder in Treating Metabolic Syndrome of Spleen Deficiency and Dampness [Phase 4]
Summary
Phase 4 clinical trial update on Wuling Powder for metabolic syndrome of spleen deficiency and dampness.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Metabolic Syndrome | Phase 4 | Status: UNKNOWN